Results 171 to 180 of about 2,655 (208)

Galcanezumab

Reactions Weekly, 2020
openaire   +1 more source

Erenumab/galcanezumab

Reactions Weekly, 2022
openaire   +1 more source

Erenumab/fremanezumab/galcanezumab

Reactions Weekly, 2021
openaire   +2 more sources

Galcanezumab CONQUERs migraine prevention

The Lancet Neurology, 2020
openaire   +2 more sources

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

Cephalalgia, 2020
David W Dodick, Peter Goadsby
exaly  

Galcanezumab/methylprednisolone/sumatriptan

Reactions Weekly, 2022
openaire   +1 more source

Erenumab/fremanezumab/galcanezumab

Reactions Weekly, 2023
openaire   +1 more source

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies

Headache, 2020
Holland C Detke, Karen H Samaan, Jessica Ailani   +2 more
exaly  

Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials

Advances in Therapy, 2021
Dulanji
exaly  

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study

European Journal of Neurology, 2022
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli   +2 more
exaly